| 000 | 01040nam a2200265 4500 | ||
|---|---|---|---|
| 001 | 4131 | ||
| 090 | _a4131 | ||
| 100 | _a20190412d1981 k||y0pory50 ba | ||
| 101 | _aeng | ||
| 102 |
_aGB _bLondres |
||
| 106 | _ar | ||
| 200 |
_aReviews on Endocrine-Related Cancer _fR.D. Bullbrook _fK. Griffiths _fP. Juret _fR.J.B. King _fW.L. McGuire _fO.H. Pearson _fS. Saez _iVol. 10 |
||
| 210 |
_aLondres _cPharmaceuticals Division of ICI _d1981 |
||
| 215 |
_a34 p. _d24,2 cm |
||
| 327 | _aAchieving a biological profile of the breast cancer patient; Interpreting response to treatment in advanced prostatic cancer; How do androgens and progestins cause regression of breast cancer?; Testing hormone responsiveness in vitro. | ||
| 606 | _aCancro da mama | ||
| 675 | _a618.19-006 | ||
| 700 | _aBulbrook, R.D. | ||
| 701 |
_4aut _aGriffiths, K. |
||
| 701 |
_4aut _aJuret, P. |
||
| 701 |
_4aut _aKing, R.J.B. |
||
| 701 |
_4aut _aMcGuire, W.L. |
||
| 701 |
_4aut _aPearson, O.H. |
||
| 701 |
_4aut _aSaez, S. |
||
| 942 | _cAM | ||